Close Menu

In PLoS Biology this week, Duke University researcher David Goldstein and his co-workers report that "synthetic associations" between rare and common variants may be behind the results of some genome-wide association studies. The conclusion is based on the team's simulation experiments as well as GWAS of sickle cell anemia and hearing loss. "[E]ven those signals that have been detected for common variants could, in principle, come from the effect of rare ones," they write.

To read the full story....

...and receive Daily News bulletins.

Already have a GenomeWeb or 360Dx account?
Login Now.

Don't have a GenomeWeb or 360Dx account?
Register for Free.

A small, early-stage trial of a combination therapy for brain cancer reports favorable responses in two patients, according to the Guardian.

Nature News writes that viral genomic surveillance in the US faces systemic issues.

President Joe Biden is seeking an increase in federal spending, including higher budgets for the National Institutes of Health and Centers for Disease Control and Prevention.

In PLOS this week: sex-stratified genome-wide association study of chronic pain, sequencing data from Indigenous Mexican groups, and more.